Matches in SemOpenAlex for { <https://semopenalex.org/work/W3130088644> ?p ?o ?g. }
- W3130088644 endingPage "10" @default.
- W3130088644 startingPage "3" @default.
- W3130088644 abstract "Thin-strut biodegradable polymer sirolimus-eluting stents (BP-SES) have been shown to reduce target lesion failure (TLF) at one-year follow-up compared with durable polymer everolimus-eluting stents (DP-EES) among patients with acute coronary syndrome (ACS). The long-term clinical benefits of thin-strut BP-SES over DP-EES in ACS patients after complete degradation of the polymer coating remain uncertain.We performed a post-hoc subgroup analysis of ACS patients included into the BIOSCIENCE randomized trial (NCT01443104). The primary endpoint was target lesion failure (TLF), a composite of cardiac death, target-vessel myocardial infarction or clinically indicated target lesion revascularization, at 5 years.Among 2119 patients enrolled between March 2012 and May 2013, 1131 (53%) presented with ACS. The 5-year cumulative incidence of TLF was significantly lower in patients with ACS compared to chronic coronary syndrome [16.5% vs. 22.9%; rate ratio (RR), 0.69; 95% confidence interval (CI), 0.57-0.85; p < 0.001]. At 5 years, TLF occurred similarly in ACS patients treated with BP-SES and DP-EES (16.9% vs. 16.0%; RR, 1.04; 95% CI, 0.78-1.41; p = 0.78). The individual components of the primary endpoint did not differ between ACS patients treated with BP-SES or DP-EES at 5 years. Overall, there was no interaction between clinical presentation and treatment effect.In a subgroup analysis of the BIOSCIENCE trial, we found no difference in long-term outcomes between ACS patients treated with BP-SES or DP-EES at 5 years." @default.
- W3130088644 created "2021-03-01" @default.
- W3130088644 creator A5010017598 @default.
- W3130088644 creator A5019587141 @default.
- W3130088644 creator A5020480277 @default.
- W3130088644 creator A5028091019 @default.
- W3130088644 creator A5032028897 @default.
- W3130088644 creator A5038409870 @default.
- W3130088644 creator A5039653690 @default.
- W3130088644 creator A5047129427 @default.
- W3130088644 creator A5048050232 @default.
- W3130088644 creator A5051530432 @default.
- W3130088644 creator A5053194091 @default.
- W3130088644 creator A5059812150 @default.
- W3130088644 creator A5061359562 @default.
- W3130088644 creator A5081653127 @default.
- W3130088644 creator A5084382893 @default.
- W3130088644 date "2022-01-01" @default.
- W3130088644 modified "2023-10-02" @default.
- W3130088644 title "Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial" @default.
- W3130088644 cites W1017377764 @default.
- W3130088644 cites W1575052200 @default.
- W3130088644 cites W1705023383 @default.
- W3130088644 cites W1846993152 @default.
- W3130088644 cites W1921048136 @default.
- W3130088644 cites W1973810123 @default.
- W3130088644 cites W2057218988 @default.
- W3130088644 cites W2089768600 @default.
- W3130088644 cites W2124385743 @default.
- W3130088644 cites W2126808665 @default.
- W3130088644 cites W2169728289 @default.
- W3130088644 cites W2274109701 @default.
- W3130088644 cites W2754054868 @default.
- W3130088644 cites W2755258852 @default.
- W3130088644 cites W2810314526 @default.
- W3130088644 cites W2888902549 @default.
- W3130088644 cites W2890691602 @default.
- W3130088644 cites W2920977580 @default.
- W3130088644 cites W2970737263 @default.
- W3130088644 cites W3005080544 @default.
- W3130088644 cites W3008329648 @default.
- W3130088644 cites W3162195278 @default.
- W3130088644 doi "https://doi.org/10.1016/j.carrev.2021.02.008" @default.
- W3130088644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33653633" @default.
- W3130088644 hasPublicationYear "2022" @default.
- W3130088644 type Work @default.
- W3130088644 sameAs 3130088644 @default.
- W3130088644 citedByCount "2" @default.
- W3130088644 countsByYear W31300886442023 @default.
- W3130088644 crossrefType "journal-article" @default.
- W3130088644 hasAuthorship W3130088644A5010017598 @default.
- W3130088644 hasAuthorship W3130088644A5019587141 @default.
- W3130088644 hasAuthorship W3130088644A5020480277 @default.
- W3130088644 hasAuthorship W3130088644A5028091019 @default.
- W3130088644 hasAuthorship W3130088644A5032028897 @default.
- W3130088644 hasAuthorship W3130088644A5038409870 @default.
- W3130088644 hasAuthorship W3130088644A5039653690 @default.
- W3130088644 hasAuthorship W3130088644A5047129427 @default.
- W3130088644 hasAuthorship W3130088644A5048050232 @default.
- W3130088644 hasAuthorship W3130088644A5051530432 @default.
- W3130088644 hasAuthorship W3130088644A5053194091 @default.
- W3130088644 hasAuthorship W3130088644A5059812150 @default.
- W3130088644 hasAuthorship W3130088644A5061359562 @default.
- W3130088644 hasAuthorship W3130088644A5081653127 @default.
- W3130088644 hasAuthorship W3130088644A5084382893 @default.
- W3130088644 hasBestOaLocation W31300886441 @default.
- W3130088644 hasConcept C126322002 @default.
- W3130088644 hasConcept C141071460 @default.
- W3130088644 hasConcept C164705383 @default.
- W3130088644 hasConcept C168563851 @default.
- W3130088644 hasConcept C203092338 @default.
- W3130088644 hasConcept C2777698277 @default.
- W3130088644 hasConcept C2777921159 @default.
- W3130088644 hasConcept C2778583881 @default.
- W3130088644 hasConcept C2779699572 @default.
- W3130088644 hasConcept C2780400711 @default.
- W3130088644 hasConcept C2781464078 @default.
- W3130088644 hasConcept C500558357 @default.
- W3130088644 hasConcept C71924100 @default.
- W3130088644 hasConcept C72563966 @default.
- W3130088644 hasConcept C88879693 @default.
- W3130088644 hasConceptScore W3130088644C126322002 @default.
- W3130088644 hasConceptScore W3130088644C141071460 @default.
- W3130088644 hasConceptScore W3130088644C164705383 @default.
- W3130088644 hasConceptScore W3130088644C168563851 @default.
- W3130088644 hasConceptScore W3130088644C203092338 @default.
- W3130088644 hasConceptScore W3130088644C2777698277 @default.
- W3130088644 hasConceptScore W3130088644C2777921159 @default.
- W3130088644 hasConceptScore W3130088644C2778583881 @default.
- W3130088644 hasConceptScore W3130088644C2779699572 @default.
- W3130088644 hasConceptScore W3130088644C2780400711 @default.
- W3130088644 hasConceptScore W3130088644C2781464078 @default.
- W3130088644 hasConceptScore W3130088644C500558357 @default.
- W3130088644 hasConceptScore W3130088644C71924100 @default.
- W3130088644 hasConceptScore W3130088644C72563966 @default.
- W3130088644 hasConceptScore W3130088644C88879693 @default.
- W3130088644 hasFunder F4320307770 @default.
- W3130088644 hasFunder F4320307771 @default.